[Full Text HTML
[Full Text PDF
] （in Japanese / 942KB）
J.Jpn. Surg. Soc.. 122(6): 625-630, 2021
TREATMENT RESULTS OF SERIOUS COVID-19 CASES IN JAPAN
COVID-19 is pneumonia triggered by a viral infection and becomes a state of acute respiratory distress syndrome as the condition progresses. Antiviral drug administration and steroids are currently in class I, but if hypoxemia worsens, ventilator and extracorporeal membrane oxygenation (ECMO) management are required. According to the CRISIS database published by Japan ECMO net, as of May 31, 2020, the number of ventilations performed was 496, the number of withdrawals was 3,790, and the number of deaths was 1,048. In addition, the number of ECMO treatments implemented was 54, the number of withdrawals was 421, and the number of deaths was 220. Japan ECMO net has launched a training program for ECMO teams, a support project for the treatment of critically ill patients, as a project of the Ministry of Health, Labor and Welfare. The treatment of severe COVID-19 cases may be difficult in a single facility alone but may be possible with the cooperation of multiple facilities, further increasing the possibility of saving lives and rehabilitating patients.
To read the PDF file you will need Adobe Reader installed on your computer.